| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -31.17M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, DMRA returned +815.1% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +32.8% |
| 1 year | +815.1% |
| 5 years | -72.5% |
| All-time high | $382.75 (Nov 2020) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in DMRA would be worth today ›No. Damora Therapeutics, Inc. has not paid a dividend in the past 12 months.
Damora Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol DMRA.
Damora Therapeutics, Inc. is part of the Healthcare sector.
Damora Therapeutics, Inc. has a market cap of 1.89B USD, based on the latest quote.
Damora Therapeutics, Inc. is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.
